DBV Technologies (DBVT) EBITDA (2020 - 2026)
DBV Technologies (DBVT) reported EBITDA of -$52.0 million for Q1 2026, down 97.72% year-over-year from -$2.3 billion in Q1 2025, and down 15.35% quarter-over-quarter from -$45.1 million in Q4 2025.
DBV Technologies (DBVT) EBITDA (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of EBITDA data on file, last reported at -$52.0 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$52.0 million, down 97.72% year-over-year; the trailing twelve-month figure through Mar 2026 was -$165.9 million (down 45.74% YoY), and the FY2025 annual result was -$140.2 million, down 18.82% from the prior year.
- EBITDA retreated to -$52.0 million in Q1 2026 per DBVT's latest filing, from -$45.1 million in the prior quarter.
- Over five years, EBITDA peaked at -$4.9 million in Q4 2023 and troughed at -$52.0 million in Q1 2026.
- A 5-year average of -$28.3 million and a median of -$26.8 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2024: EBITDA jumped 73.88% in 2023, then sank 442.97% in 2024.
- A 5-year view of EBITDA shows it stood at -$18.9 million in 2022, then jumped by 73.88% to -$4.9 million in 2023, then slumped by 442.97% to -$26.8 million in 2024, then sank by 67.96% to -$45.1 million in 2025, then retreated by 15.35% to -$52.0 million in 2026.
- Business Quant data shows DBVT's EBITDA at -$52.0 million in Q1 2026, -$45.1 million in Q4 2025, and -$34.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.00 Mn |
| Dec 31, 2025 | -45.08 Mn |
| Sep 30, 2025 | -34.00 Mn |
| Jun 30, 2025 | -34.84 Mn |
| Mar 31, 2025 | -26.30 Mn |
| Dec 31, 2024 | -26.84 Mn |
| Sep 30, 2024 | -26.66 Mn |
| Jun 30, 2024 | -34.05 Mn |
| Mar 31, 2024 | -30.43 Mn |
| Dec 31, 2023 | -4.94 Mn |
| Sep 30, 2023 | -20.66 Mn |
| Jun 30, 2023 | -24.48 Mn |
| Mar 31, 2023 | -16.98 Mn |
| Dec 31, 2022 | -18.92 Mn |
| Sep 30, 2022 | -32.67 Mn |
| Jun 30, 2022 | -34.23 Mn |
| Mar 31, 2022 | -18.62 Mn |
| Dec 31, 2021 | -16.24 Mn |
| Sep 30, 2021 | -27.73 Mn |
| Jun 30, 2021 | -27.82 Mn |